Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa
Diagnostics · 14.02.2023 · 13 (4) · 730
DOI: 10.3390/diagnostics13040730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 14.02.2023. Verfasst von Anna Wawrocka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Poznan University of Medical Sciences, 60-806 Poznan, Poland. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Center Poland.
Abstract (Originalsprache)
Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of disorders with progressive loss of photoreceptor and pigment epithelial function. Nineteen unrelated Polish probands clinically diagnosed with nonsyndromic RP were recruited to this study. We used whole-exome sequencing (WES) to identify potential pathogenic gene variants in molecularly undiagnosed RP patients, as a molecular re-diagnosis after having performed targeted NGS in the past. Targeted NGS allowed for identification of the molecular background in only 5 out of 19 patients. Fourteen patients who remained unsolved despite the targeted NGS were subjected to WES. WES revealed potentially causative variants in RP-related genes in another 12 patients. Together, NGS methods revealed the coexistence of causal variants affecting distinct RP genes in 17 out of 19 RP families, with a very high efficiency of 89%. With the improvement of NGS methods, including higher sequencing depth, broader target enrichment, and better bioinformatic analysis capabilities, the ratio of identified causal gene variants has significantly increased. Therefore, it is important to consider repeating high-throughput sequencing analysis in those patients in whom the previously performed NGS did not reveal any pathogenic variants. The study confirmed the efficiency and clinical utility of re-diagnosis with WES in molecularly undiagnosed RP patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
- Biometry and Bioinformatics Team, Institute of Plant Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
- Centers for Medical Genetics GENESIS, 60-529 Poznan, Poland.
ORCID-Profile: Magdalena Socha, Joanna Walczak-Sztulpa, Grzegorz Koczyk, Anna Skorczyk-Werner, Maciej R Krawczyński
Förderung
- National Science Center
- National Science Center Poland
Zitieren
APA
Wawrocka, A., Socha, M., Walczak-Sztulpa, J., Koczyk, G., Skorczyk-Werner, A., & Krawczyński, M. R. (2023). Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa. Diagnostics, 13(4), 730. https://doi.org/10.3390/diagnostics13040730
Vancouver
Wawrocka A, Socha M, Walczak-Sztulpa J, Koczyk G, Skorczyk-Werner A, Krawczyński MR. Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa. Diagnostics. 2023;13(4):730. doi:10.3390/diagnostics13040730
BibTeX
@article{Wawrocka2023,
author = {Wawrocka, Anna and Socha, Magdalena and Walczak-Sztulpa, Joanna and Koczyk, Grzegorz and Skorczyk-Werner, Anna and Krawczyński, Maciej R},
title = {Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {4},
pages = {730},
doi = {10.3390/diagnostics13040730}
}
EUVIMED